Bionx keeps its lead in the knee repair market with its resorbable Meniscus Arrow
This article was originally published in Clinica
There could soon be a new player in the $100 million meniscal repair market in the US. But Bionx Implants, the company which claims to have created the sector when it launched its flagship product - the Meniscus Arrow - little more than a year ago, is confident of retaining its leadership position.
You may also be interested in...
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.